Our multi-omic discovery platform has been designed to bridge the gap between laboratory research and clinically scalable applications. Through ongoing research and collaboration, MiND Biosciences is progressing molecular discoveries towards potential diagnostic, prognostic and disease-monitoring tools for neurodegenerative disease.
Building a platform for future clinical translation
